DK175318B1 - Levende vaccine mod Newcastle disease-virusstamme og anvendelse af stammen - Google Patents

Levende vaccine mod Newcastle disease-virusstamme og anvendelse af stammen Download PDF

Info

Publication number
DK175318B1
DK175318B1 DK198903471A DK347189A DK175318B1 DK 175318 B1 DK175318 B1 DK 175318B1 DK 198903471 A DK198903471 A DK 198903471A DK 347189 A DK347189 A DK 347189A DK 175318 B1 DK175318 B1 DK 175318B1
Authority
DK
Denmark
Prior art keywords
strain
vaccination
ndw
virus
birds
Prior art date
Application number
DK198903471A
Other languages
Danish (da)
English (en)
Other versions
DK347189D0 (da
DK347189A (da
Inventor
Nico Van Wiltenburg
Original Assignee
Dimminaco Ag Sa Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimminaco Ag Sa Ltd filed Critical Dimminaco Ag Sa Ltd
Publication of DK347189D0 publication Critical patent/DK347189D0/da
Publication of DK347189A publication Critical patent/DK347189A/da
Application granted granted Critical
Publication of DK175318B1 publication Critical patent/DK175318B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK198903471A 1988-07-18 1989-07-13 Levende vaccine mod Newcastle disease-virusstamme og anvendelse af stammen DK175318B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8801819 1988-07-18
NL8801819 1988-07-18

Publications (3)

Publication Number Publication Date
DK347189D0 DK347189D0 (da) 1989-07-13
DK347189A DK347189A (da) 1990-01-19
DK175318B1 true DK175318B1 (da) 2004-08-16

Family

ID=19852645

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198903471A DK175318B1 (da) 1988-07-18 1989-07-13 Levende vaccine mod Newcastle disease-virusstamme og anvendelse af stammen

Country Status (9)

Country Link
US (1) US5149530A (ja)
EP (1) EP0351908B1 (ja)
JP (1) JP2655726B2 (ja)
AT (1) ATE112490T1 (ja)
DE (1) DE68918649T2 (ja)
DK (1) DK175318B1 (ja)
ES (1) ES2060740T3 (ja)
HU (1) HU204439B (ja)
IE (1) IE65736B1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250298A (en) * 1988-10-07 1993-10-05 University Of Delaware Live attenuated newcastle disease virus vaccines and preparation thereof
FR2682966B1 (fr) * 1991-10-29 1994-12-02 Rhone Merieux Preparation d'antigenes et de vaccins du virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie.
CA2181862C (en) * 1995-08-01 2009-12-22 Carla Christina Schrier Mild newcastle disease virus vaccine
DK0770397T3 (da) * 1995-10-18 2004-08-09 Akzo Nobel Nv Newcastle disease viruskombinationsvaccine
EP0848956A1 (en) * 1996-12-17 1998-06-24 Dimminaco Ag/Sa/Ltd. In ovo vaccination against Newcastle Disease
TW200502402A (en) * 2002-12-06 2005-01-16 Wyeth Corp Escape mutants of newcastle disease virus as marker vaccines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798835A (en) * 1954-01-18 1957-07-09 American Cyanamid Co Newcastle disease and infectious bronchitis vaccines and production thereof
US3876763A (en) * 1970-12-29 1975-04-08 Shionogi & Co Infectious coryza infectious bronchitis and newcastle disease vaccines and production thereof
US4053583A (en) * 1976-03-01 1977-10-11 Smithkline Corporation Live newcastle disease virus vaccines
BE853923A (fr) * 1977-04-25 1977-10-25 Rit Rech Ind Therapeut Nouveau vaccin vivant ameliore contre le pseudopeste aviaire et son procede de preparation
EP0009277B1 (en) * 1978-09-14 1984-04-18 Gist-Brocades N.V. Combined vaccine active against newcastle disease and egg production drop caused by adeno-like viruses, process for preparing it, adeno-like and newcastle disease virus strains
SU826584A1 (ru) * 1979-10-29 1982-11-07 Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Вакцина против ньюкаслской болезни птиц,способ ее изготовлени и способ профилактики ньюкаслской болезни птиц

Also Published As

Publication number Publication date
DE68918649D1 (de) 1994-11-10
ES2060740T3 (es) 1994-12-01
DK347189D0 (da) 1989-07-13
IE65736B1 (en) 1995-11-15
IE892284L (en) 1990-01-18
ATE112490T1 (de) 1994-10-15
HU204439B (en) 1992-01-28
US5149530A (en) 1992-09-22
EP0351908A1 (en) 1990-01-24
EP0351908B1 (en) 1994-10-05
HUT52703A (en) 1990-08-28
DK347189A (da) 1990-01-19
DE68918649T2 (de) 1995-03-23
JP2655726B2 (ja) 1997-09-24
JPH0269422A (ja) 1990-03-08

Similar Documents

Publication Publication Date Title
Cook et al. A live attenuated turkey rhinotracheitis virus vaccine. 2. The use of the attenuated strain as an experimental vaccine
Ideris et al. Vaccination of chickens against Newcastle disease with a food pellet vaccine
US7462479B2 (en) Infectious bronchitis virus vaccine
RU2528750C2 (ru) Рекомбинантная вакцина на основе инактивированного вирусного вектора
FI59535C (fi) Foerfarande att tillverka levande virusvaccin foer newcastle-sjukdom
DK175318B1 (da) Levende vaccine mod Newcastle disease-virusstamme og anvendelse af stammen
Majiyagbe et al. Antibody response to strain combinations of Newcastle disease virus as measured by hemagglutination-inhibition
Gough et al. Immune response to monovalent and bivalent Newcastle disease and infectious bronchitis inactivated vaccines
US4320115A (en) Rabies virus vaccine
JP3945842B2 (ja) 弱毒性ニューカッスル病ウイルスワクチン
MXPA96003124A (en) Vaccine against the newcastle beni disease virus
JP4050312B2 (ja) ニワトリ貧血因子ブロイラーワクチン
CZ282443B6 (cs) Očkovací látka pro prevenci infekční bursitidy u drůbeže a způsob její výroby
Crick The vaccination of man and other animals against rabies
Mazija et al. Immunogenicity and safety of La Sota strain of Newcastle disease virus administered to newly hatched chicks by nebulization
KR102656435B1 (ko) 신규한 가금 아데노바이러스 및 이를 유효성분으로 포함하는 가금 아데노바이러스 다가백신
DK165359B (da) Vaccine mod smitsom bronkitis hos daggamle kyllinger, samt virusstamme indeholdt i vaccinen
Huang et al. Rabies virus vaccines
Donahoe Inactivated avian influenza whole virus vaccines
Gupta et al. Comparative efficacy of cell culture inactivated vaccines against hydropericardium syndrome in broilers
TANENO et al. Safety and efficacy of the cell-associated vaccine prepared by an attenuated infectious laryngotracheitis virus
WO2021011465A1 (en) Method for vaccinating avians against reovirus
RU2127603C1 (ru) Инактивированная вакцина против инфекционной бурсальной болезни птиц
RU1822792C (ru) Вакцина против инфекционного бронхита кур
Darwish et al. Preparation of Inactivated St. Louis Encephalitis Virus Vaccine from Hamster Kidney Cell Culture.

Legal Events

Date Code Title Description
PUP Patent expired